Awareness of HIV prevention strategies under development: Word on the street

Journal of Acquired Immune Deficiency Syndromes

Volumn 48, Issue 2, 2008, Pages 232-234

  Koblin, Beryl A ^a   Murrill, Christopher ^b   Xu, Guozhen ^a   Camacho, Michael ^c   Liu, Kai Lih ^b   Raj Singh, Shavvy ^b   Torian, Lucia ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

AFRICA; ANUS INTERCOURSE; DISEASE ASSOCIATION; DRUG EFFICACY; GENITAL HERPES; HEALTH SURVEY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LETTER; MALE HOMOSEXUAL; PERU; PRIORITY JOURNAL; SEXUAL BEHAVIOR; ADULT; HOMOSEXUALITY; IMMUNOLOGY; MALE; PATIENT EDUCATION;

ADULT; AIDS VACCINES; HERPES GENITALIS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; RISK-TAKING;

EID: 46449099589     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318174391e     Document Type: Letter

References (13)

1. Johnston MI, Fauci AS. An HIV vaccined evolving concepts. N Engl J Med. 2007;356: 2073-2081.
2. Celum C, Wald A, Hughes J, et al. HSV-2 suppression to prevent HIV acquisition (HPTN 039): characteristics, study drug adherence and retention of study participants. Presented at: 14th Conference on Retroviruses and Opportunistic Infections, in Los Angeles, CA, 2007.
3. Liu AY, Grant RM, Buchbinder SP. Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006;296:863-865.
4. Flynn NM, Forthal DN, Harro CD, et al. Placebo-controlled phase 3 trial of a recombi-nant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis. 2005;191:654-665.
5. Altman LK, Pollack A. Failure of vaccine test is setback in AIDS fight. New York Times. September 22, 2007.
6. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of 2 overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35:435-445.
7. Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006;164:733-741.
8. Celum C, Wald A, Hughes J, et al, and HPTN 039. HSV-2 suppressive therapy for prevention of HIVacquisition: results of HPTN 039. Presented at: 15th Conference on Retro-viruses and Opportunistic Infections; 2008; Boston.
9. Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccu-pational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1-20.
10. Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors - United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ. 2006;55:1-16.
11. MacKellar D, Valleroy L, Karon J, et al. The Young Men's Survey: methods for estimating HIV seroprevalence and risk factors among young men who have sex with men. Public Health Rep. 1996;111(Suppl 1): 138-144.
12. Koblin BA, Murrill C, Camacho M, et al. Amphetamine use and sexual risk among men who have sex with men: results from the National HIV Behavioral Surveillance Study-New York City. Subst Use Misuse. 2007;42: 1613-1628.
13. Liu A, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47:241-247.